HB970: Health Insurance - Insulin - Prohibition on Step Therapy or Fail-First Protocols
Legislative Summary
Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from imposing a step therapy or fail-first protocol for insulin or an insulin analog used to treat an insured's or enrollee's Type 1, Type 2, or gestational diabetes; and applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2026.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
Favorable with Amendments 953925/1 Adopted
Favorable with Amendments 953925/1 Adopted
Favorable with Amendments 353129/1 Adopted
Favorable with Amendments 353129/1 Adopted
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
